Searched for
COVID RNA THERAPY
Cipla is aiming for 40-50 global product filings in three years, says MD Achin GuptaCipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...
Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEOAs Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...
COVID-19 vaccines may help some cancer patients fight tumorsNew research suggests COVID-19 mRNA vaccines could help cancer patients. Those with advanced lung or skin cancer who received Pfizer or Mod...
Cancer cure? Russia commences human trials of revolutionary personalized cancer vaccineRussia's Gamaleya Center, famed for Sputnik V, will initiate human trials for a personalized mRNA melanoma vaccine by late 2025. This innov...
Cancer cure found? Scientists create a new mRNA vaccine that triggers strong anticancer immune response against tumoursUniversity of Florida scientists have engineered an experimental mRNA vaccine that stimulates the immune system to combat tumors in conjunc...
Covid-19's surprising link to Cancer treatment: New study shows tumour shrinkage potentialResearchers have discovered that the Covid-19 virus may hold unexpected benefits for cancer treatment. The virus triggers the formation of ...
New cancer vaccine that trains body's immune system to destroy cancer cells shows promising resultsCancer Vaccine: A new mRNA cancer vaccine developed by Moderna has shown promising early results in clinical trials. The vaccine, mRNA-4359...
Cipla makes additional investment in German mRNA biotechEthris' has four potential drugs under development pipeline, of which one is for treating uncontrolled asthma and three other for primary c...
Good mRNA! A Nobel breakthrough storyImmunologist Drew Weissman and biochemist Katalin Kariko have been awarded the 2023 Nobel Prize in Physiology or Medicine for their discove...
Cancer vaccines are being developed using tech similar to that used for Covid shotsDecades before Covid vaccines, scientists had been working on messenger ribonucleic acid (mRNA) vaccines targeting cancer.
Countries which chose Covishield fared better than those that took mRNA vax: Adar PoonawallaCovovax, which is our Novavax product, is proven to be the best against Omicron and Omicron sub variants. It is also the only vaccine from ...
RNA-based therapy can protect from many Covid variants: StudyResearchers at Yale School of Medicine in the US noted that the molecule could lead to new treatments for COVID-19 in immunocompromised pat...
Scientists developing chewing gum that could reduce SARS-CoV-2 transmissionIncubating samples obtained from nasopharyngeal swabs from Covid-positive patients with the gum, they showed that the ACE2 present could ne...
Seeing good demand for biologics manufacturing: Syngene CEO Jonathan HuntIn an interview to ET, Jonathan Hunt, CEO and MD of Syngene said the company has spare capacity and is also investing on expansion of micro...
AstraZeneca invests in Imperial's self-amplifying RNA technology with eye on future drugsVaxEquity, a startup founded by Imperial vaccinologist Robin Shattock, could receive up to $195 million if certain milestones are met, in a...
A cure for cancer: After Covid vaccine, next mRNA miracle might be closer than you imagineThe new technology was not only lightning fast but also incredibly effective - mRNA Covid vaccines from both Moderna and Pfizer hit the bul...
Indian scientists developing mRNA vaccine get funding from Ignite LSFThe three-year grant will fund research to develop the platform technologies for mRNA vaccine development including for the new variants of...
Real-Life vaccination as clinical trialsAcross the world, Covid-19 vaccines have been given emergency approvals. Basically, long and protracted trials that vaccines developers ord...
Study shows Favipiravir provides multiple benefits in COVID-19 treatment: GlenmarkThe Phase 3 study with Favipiravir, sold under the brand name FabiFlu, by the company was conducted in 150 patients, it added. Favipiravir ...
Mildly ill COVID-19 patients might be discharged in nine or more days after symptom onset: StudyScientists have assessed respiratory samples from 35 COVID-19 patients, and found that contagious coronavirus was "rarely detectable" beyon...